首頁 › 急性淋巴母細胞性白血病 › 田納西州 › Nashville
Nashville, TN 的 急性淋巴母細胞性白血病 臨床試驗
8 項針對 急性淋巴母細胞性白血病 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
招募中2 期
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of CTD402 in T-ALL/LBL Patients
招募中1/2 期
- Sarah Cannon Research Insitute, Nashville
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
招募中觀察性研究
- Vanderbilt University Medical Center, Nashville
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
招募中1/2 期
- Research Site, Franklin · 距離 17 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Vanderbilt University, Nashville
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- TriStar Centennial Medical Center, Nashville
HPC Offered for PRESERVE Expansion
招募中觀察性研究
- Tristar Centennial Medical Center, Nashville
其他城市的 急性淋巴母細胞性白血病 試驗
- Houston, TX28 項研究
- New York City, NY23 項研究
- Seattle, WA21 項研究
- Baldwin Park, CA21 項研究
- Chicago, IL20 項研究
- Atlanta, GA19 項研究
- Memphis, TN16 項研究
- Washington, DC16 項研究
- Philadelphia, PA16 項研究
- Boston, MA15 項研究
- Los Angeles, CA14 項研究
- Mountain View, CA13 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌81 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。